NCT01592305View on ClinicalTrials.gov

A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

atazanavir

multiple oral doses

DRUG

danoprevir

multiple oral doses

DRUG

ritonavir

multiple oral doses

DRUG

tenofovir disoproxil fumarate

single oral doses

Trial Locations (1)

66219

Lenexa

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01592305 - A Study of Drug-Drug Interaction Between Danoprevir Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir | Biotech Hunter | Biotech Hunter